BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23104519)

  • 1. Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.
    Hata M; Koike I; Maegawa J; Kaneko A; Odagiri K; Kasuya T; Minagawa Y; Kaizu H; Mukai Y; Inoue T
    Strahlenther Onkol; 2012 Dec; 188(12):1102-7. PubMed ID: 23104519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid.
    Hata M; Koike I; Omura M; Maegawa J; Ogino I; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):605-11. PubMed ID: 21300468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Metastatic Eyelid Carcinoma.
    Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
    J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy: conjunctival and eyelid tumors.
    Aronow ME; Singh AD
    Dev Ophthalmol; 2013; 52():85-93. PubMed ID: 23989129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial high-dose-rate brachytherapy in eyelid cancer.
    Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
    Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature.
    Yen MT; Tse DT; Wu X; Wolfson AH
    Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):211-5. PubMed ID: 10826762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients.
    Krengli M; Masini L; Comoli AM; Negri E; Deantonio L; Filomeno A; Gambaro G
    Strahlenther Onkol; 2014 Mar; 190(3):245-9. PubMed ID: 24424628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy for Primary Eyelid Cancers in Tunisia.
    Belaid A; Nasr C; Benna M; Cherif A; Jmour O; Bouguila H; Benna F
    Asian Pac J Cancer Prev; 2016; 17(7):3643-6. PubMed ID: 27510024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiation therapy of malignant eyelid tumors].
    Morozov AI; Chentsova OB; Korshunov AI; Biriukov VA
    Med Radiol (Mosk); 1986 Mar; 31(3):17-20. PubMed ID: 3959793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
    Lee IJ; Koh JY
    Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.
    Cook BE; Bartley GB
    Ophthalmology; 2001 Nov; 108(11):2088-98; quiz 2099-100, 2121. PubMed ID: 11713084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eyelid carcinoma: An experience from a tertiary cancer center.
    Thiagarajan S; Bahani A; Chaukar D; Dcruz AK
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S48-S52. PubMed ID: 33380651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience.
    Ho M; Liu DT; Chong KK; Ng HK; Lam DS
    Hong Kong Med J; 2013 Apr; 19(2):150-5. PubMed ID: 23535675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct eyelid defect closure: a prospective study of functional and aesthetic outcomes.
    Thaller VT; Madge SN; Chan W; Vujic I; Jazayeri F
    Eye (Lond); 2019 Sep; 33(9):1393-1401. PubMed ID: 30944462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of eyelid sebaceous carcinomas.
    Dogru M; Matsuo H; Inoue M; Okubo K; Yamamoto M
    Ophthalmologica; 1997; 211(1):40-3. PubMed ID: 8958530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes.
    Song A; Carter KD; Syed NA; Song J; Nerad JA
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):194-200. PubMed ID: 18520834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid.
    Conill C; Sánchez-Reyes A; Molla M; Vilalta A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1326-9. PubMed ID: 15275716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collision sebaceous and basal cell carcinomas of the eyelid.
    Levy J; Cagnano E; Benharroch D; Monos T; Lifshitz T
    Ann Diagn Pathol; 2006 Jun; 10(3):157-9. PubMed ID: 16730311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival rates in sebaceous carcinoma of the eyelid.
    Muqit MM; Roberts F; Lee WR; Kemp E
    Eye (Lond); 2004 Jan; 18(1):49-53. PubMed ID: 14707966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.
    Zhou C; Wu F; Chai P; Shi Y; Ye J; Shi X; Tan J; Ding Y; Luo Y; Esmaeli B; Jia R; Fan X
    J Am Acad Dermatol; 2019 Jun; 80(6):1608-1617.e1. PubMed ID: 30639290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.